Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-06

Clinical Trial Update: Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study assessing the safety and tolerability of CV8102 alone and in combination with a rabies virus vaccine in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CV8102 (CV8102)
  • Rabies virus vaccine (rabies vaccine)

Snippet

Sponsor: CureVac | Conditions: Rabies | Phase 1 | Status: COMPLETED